Health
New Metastatic Cervical Cancer Treatments Give Hope – Targeted Oncology
Investigators treating patients with gynecologic malignancies are optimistic that multiple clinical trials exploring new second-line cervical cancer treatments…
Investigators treating patients with gynecologic malignancies are optimistic that multiple clinical trials exploring new second-line cervical cancer treatments will result in a much-anticipated breakthrough for the field, with improved response rates from these new strategies already generating excitement.
In an interview with Targeted Therapies in Oncology(TTO), R. Wendel Naumann, MD, discussed the phase 1/2 CheckMate 358 trial (NCT02488759) in which patients received the PD-1 inhibitor nivolumab…
-
Noosa News13 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business15 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business17 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General22 hours agoHopes for peace but pain lingers on Oct 7 anniversary